Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

re: "Perhaps the ApoE4 gene provided a survival

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/29/2021 7:00:00 AM
Anavex Life provides key updates on clinical trials in rare genetic neurological disorders Seeking Alpha - 11/24/2021 9:40:36 AM
Anavex Life Sciences EPS misses by $0.39 Seeking Alpha - 11/24/2021 7:07:01 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results GlobeNewswire Inc. - 11/24/2021 7:00:00 AM
Notable earnings after Wednesday's close Seeking Alpha - 11/23/2021 5:35:23 PM
Anavex Life Sciences FY 2021 Earnings Preview Seeking Alpha - 11/23/2021 1:20:23 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/23/2021 10:42:34 AM
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 GlobeNewswire Inc. - 11/17/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference GlobeNewswire Inc. - 10/15/2021 7:00:00 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 10/13/2021 7:00:00 AM
Cassava down after phase 3 simufilam announcement; other Alzheimer's names follow Seeking Alpha - 10/6/2021 12:51:22 PM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/28/2021 8:00:00 AM
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021 GlobeNewswire Inc. - 9/27/2021 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:11:01 AM
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® GlobeNewswire Inc. - 9/27/2021 7:00:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 9/24/2021 5:05:26 PM
Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today!  Register Now InvestorsHub NewsWire - 9/15/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today.  Register Now InvestorsHub NewsWire - 9/1/2021 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Autism) GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 5:13:54 PM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results GlobeNewswire Inc. - 8/12/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021 GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
apostrophe   Sunday, 07/16/17 04:16:06 PM
Re: Fentil post# 111263
Post # of 338770 
re: "Perhaps the ApoE4 gene provided a survival advantage in ancient environments. Today only about a quarter of us have a single copy of the ApoE4 gene, and only about two in a hundred carry a double dose. But DNA analysis of ancient bones shows that thousands of years ago, the ApoE4 genotype was ubiquitous in humans. The gene — which helps to generate cholesterol — might have been a crucial step in the development of our big, energy-hungry brains, and it may have played a key role in defending those brains from pathogenic invaders."

In case an additional opinion on the article may be of interest.:

In a previous post, I noted that Innuits have no AD and theorized that it may be due to their "Paleo" diet. Basically this refers to the Paleolithic prehistoric era wherein our ancestors mainly ate meat, and little else. The Tsimane tribe also appears to derive most of their nutrition from hunting. Besides fairing better in regard to CNS disease, the researchers found that the Tsimane "have the cleanest arteries of any population that has ever been studied, meaning that they may be largely immune to heart disease."

The researchers see a possible link to them having certain parasites in their systems. Well. Maybe. But one thing we haven't really covered in any discussion I've seen so far is, what picks up the S1 receptor naturally? The corollary being that it isn't being triggered properly when needed in modern civilization humans, probably due to our necessity of eating mass produced food. I'm thinking the high lectin load in popular carbohydrates being pushed as "healthy", not to mention sugar, various chemicals like Roundup showing up in everything from baby formula to vaccines...

The phrase, "a key role in defending those brains from pathogenic invaders." may be the gene and/or response to parasites but, somehow the natural S1 triggering/modulation protocol is being dusrupted. Giving the S1 receptor constellation a little help (via 2-73) would explain the dramatic "unexpectedly" positive results seen thus far. It also appears that not just any S1 agonist will do.

I'm not about to give up my favorite modern foods any more than I would want wild parasites (there seems to be a friend or foe situation with that). Even if one can achieve the right stuff in their gut it's likely the S1 system is still being screwed up by a constant input of negative influences and thusly still benefits from the delicate antidote effects of 2-73.

It is also a bit irksome that the article ends with apparent obligatory pumping of amyloid obliteration even though the researchers report wasn't about that. I suppose we'll have to keep expecting information for public consumption to be "managed" in favor of entrenched paradigms. At least for a while yet here.

https://www.nytimes.com/2017/07/14/opinion/sunday/alzheimers-cure-south-america.html


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences